Table 3.
Animal ID | Age | Immunogen | Dose and route | Comments | Boost |
---|---|---|---|---|---|
A. H636, H642, H615 | Adult | vapA + IL-12 (1 mg each, mixed) | 0.5 mg i.d. 0.5 mg i.t. |
i.d. divided between 10 sites i.t. single injection |
Day 14—same protocol as primary |
B. H607, H624, H563 | Adult | vapA + control plasmid | Same as (A) | Same as (A) | Same as (A) |
C. H670, H669, H672, H673 | Foals | vapA + IL-12 (1 mg each, mixed) | 0.5 mg i.d. 0.5 mg i.n. |
i.d. divided between 10 sites i.n. one dose Prime-Boost* |
Day 14—same (DNA) Day 30—rVapA protein*: i.d. 10 μg × 10 sites (100 μg total) + Ribi™ adjuvant; +100 μg protein i.n. |
D. H629, H633, A2166, JJ, MM | Foals | vapA plasmid [20] | Same as (C) | Same as (C) | Same as (C) |
E. H630, H632, A2167, JH, Elly | Foals | vapA control plasmid [20] | Same as (C) | Same as (C) | Same as (C) |
F. A2201, A2185 | Adult | p15/p26 + IL-12 (5 mg each, mixed) | 2.5 mg i.d. 2.5 mg i.t. |
i.d. divided between 10 sites i.t. single injection |
Day 15, 43–57, 57–71 |
G. A2190, A2192 | Adult | p15/p26 + control | Same as (F) | Same as (F) | Same as (F) |
H. A2222, A2223, A2224 | Foals | p15/p26 alone (no IL-12) | Same as (F) | Same as (F) | Day 15, 36, 50 |
DNA prime + boost with recombinant protein.